Immunotherapies Xchange - San Diego - 2025

Translational Immunology
- Translational Immunology
16:20 17:20

Increasing reproducibility and translatability of findings to human applications

Cristiano Sacchetti, Associate Director - Bioanalytical - Translational Biology - Arcturus Therapeutics
Immune Regulation
- Immune Regulation
16:20 17:20

Avoiding recurrence of infection and minimising autoimmunity-induced side effects
Immunogenicity
- Immunogenicity
16:20 17:20

Predicting immunogenicty in diverse populations to reduce variability in safety

Snezana Milutinovic, Associate Director, Translational Research - Radionetics Oncology
Clinical Development
- Immune Regulation
15:15 16:15

Sponsor-Led Poster Presentation: Targeting Regulatory T Cells to Modulate Inflammatory Responses in Chronic Diseases
Immunogenicity
- Immunogenicity
15:15 16:15

Sponsor-Led Poster Presentation: Advancing Predictive Models for Assessing Immunogenicity of Biologic Therapeutics: Integration of In Silico and In Vitro Methods
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
15:05 15:15

Afternoon Refreshments
Clinical Development
- Clinical Development
11:25 12:25

Start with the End Goal in Mind: Efficiency in Creating Methods for Bioanalytical Endpoints in ADA, PK, and PD Assays
Immune Regulation
- Immune Regulation
11:25 12:25

Avoiding recurrence of infection and minimising autoimmunity-induced side effects
Clinical Development
- Clinical Development
09:05 10:05

Adapting drugs to the dynamic and evolving tumor microenvironment (TME) during tumor progression

Understanding TME. Strategies for Adaptation. Innovative Drug Design.

Rajesh Sharma, Director of Pharmacology - Tentarix Biotherapeutics
Translational Immunology
- Translational Immunology
09:05 10:05

Data integration and interoperability in multi-omics approaches to identify disease biomarkers

Peter Szabo, Head of Translation Medicine - Oncology - Insitro
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
17:20 18:20

Evening Drinks Reception
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
14:35 15:05

1-2-1 Meetings / Networking Break
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
14:00 14:30

1-2-1 Meetings / Networking Break
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
13:25 13:55

Spotlight Presentation
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
12:25 13:25

Networking Lunch
Translational Immunology
- Translational Immunology
11:25 12:25

Application of multi-omics approaches to dissect immune responses and identify disease-associated biomarkers
Immunogenicity
- Immunogenicity
11:25 12:25

Modulating the immune response to prevent immunogenicity/ anti-drug antibodies
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
11:15 11:25

Morning Refreshments
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
10:45 11:15

1-2-1 Meetings / Networking Break
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
10:10 10:40

1-2-1 Meetings / Networking Break
Immune Regulation
- Immune Regulation
09:05 10:05

Precision targeting without broad immunosuppresion for autoimmune diseases

Current Challenges: What are the primary limitations of existing broad immunosuppressive therapies i ...

Doug Ethell, Founder and Chief Executive Officer - Leucadia Therapeutics
Clinical Development
- Clinical Development
15:15 16:15

Sponsor-Led Poster Presentation: Optimization of Immunotherapy Trial Designs: Insights from Real-World Data on Biomarker-Driven Patient Stratification
Translational Immunology
- Translational Immunology
15:15 16:15

Sponsor-Led Poster Presentation: Leveraging Single-Cell Multi-Omics to Uncover Immune Cell Dynamics in Autoimmune Diseases
Immunogenicity
- Immunogenicity
09:05 10:05

Predicting and mitigating immunogenicity: From preclinical Insights to clinical translation

Shicheng Guo, Director - Arrowhead Pharma
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
08:30 09:00

Opening Address & Keynote Presentation
- Clinical Development
- Immune Regulation
- Immunogenicity
- Translational Immunology
08:00 08:30

Registration